ESC 365 - Safety and efficacy of DAPAGLIFLOZIN in patients with systemic right ventricular dysfunction: Preliminary results

Open Access

Safety and efficacy of DAPAGLIFLOZIN in patients with systemic right ventricular dysfunction: Preliminary results

Session: Session 4: Top 5 Abstract Oral Presentations

Topic: Adult Congenital Heart Disease (ACHD)

Speaker: Doctor M. Albertini (Paris, FR)

Event: EuroACHD 2024

Seminar Presentation

Add to my library

About the speaker

Doctor Mathieu Albertini

Paris (France)

1 presentation

0 follower

4 more presentations in this session

A validated mortality score for adults with a Fontan circulation: Fontan Adult Brompton (FAB) score

Speaker: Doctor A. Arvanitaki (Thessaloniki, GR)

Single center experience in treatment of adults with Fontan circulation using Sodium Glucose Cotransporter-2 inhibitors

Speaker: Doctor P. Skorek (Krakow, PL)

A review of more than 2 decades of Heart Lung Transplants at The Freeman Hospital

Speaker: Doctor A. Henry (Johor Bahru, MY)

Risk of heart failure after cancer diagnosis in CHD - patients

Speaker: Doctor C. Karazisi (Gothenburg, SE)

Access the full session

Session 4: Top 5 Abstract Oral Presentations

Speakers: Doctor M. Albertini, Doctor A. Arvanitaki, Doctor P. Skorek, Doctor A. Henry, Doctor C. Karazisi

About the event

EuroACHD 2024

14 April - 16 April 2024

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources